Sign up
Pharma Capital

TRxADE Group gains momentum as it brings buyers and sellers of pharmaceutical products together

TRxADE Group Inc (OTCQB: TRXD) Chairman and CEO Suren Ajjarapu tells Proactive Investors the company is showing momentum, with one major project started and another set to begin.

TRxADE is a web-based market platform with 8,900 registered independent pharmacy customers. It enables its customers to quickly source and purchase pharmaceuticals, accessories and services from a wide range of manufacturers and drug distributors.

Ajjarapu says acquisitions are on the horizon and the company hopes to uplist to the NASDAQ.

 

View full TRXD profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.